Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
utilizing the latest RRR #s in PCI 965k (32%) and CABG 200k (39%) accessing each cost at $30k and $100k respectively the potential savings in US alone is 9.8 bil and 7.2 bil. With the latest Qaly Vascepa should be prescribed like pez… I know I swallow 4 g's a day off label
So sad to hear about the person who had an MI with stint and didn't get Vascepa approval
Jesse, i'm with you 100% having said that my conspiracy mind says this may be a one off ie look the other way on this one but if BP owned the molecule then don't look the other way... I have a bunch of dough saying it gets reversed for exactly what you are opining plus i'm on the molecule and my labs are superb by comparison... EVERY type 2 in the world would benefit from 4 g's daily
Fabio, they don't have the right crew hammering the payors.. I suspect they don't because they didn't think this would be in their problem but Du thought differently
glad I can be of service
I've been long since 09' I've been on 4 g's of V for 2 years daily. I've been an investor for 35 years and a biotech investor for over 10 years. Having spewed all this, I've never seen a stock so beleaguered in all this time. Say what you want about the SPA rescindment, the subsequent dilution to get reduce it to the finish line, the NCE debacle, the top line readout in sept 2018, then the mineral oil fiasco, the FDA delay in fast track and the Du decision .. i'm exhausted!! I own 60k shares and for the life of me I've never seen a more life saving molecule with this safety profile be completely decimated by 'events' … even before the Du decision this PPS never got close to its US and ROW opportunity. i'm not selling a share i'll go down with the ship if need be i'm insane over this f'n stock
Here are my labs after 2 years of continuous use of Vascepa 4 g's daily
PSA .2
Cholesterol 163
Chol/HDL ratio 3.3
HDL Cholest 50
LDL CHolest 103 a bit high
Non HDL Cholest 113
Trig's 50
VLDL cholest 10
A1C 5.6 2 years ago it was 6.2
all my labs have continued to improve since being on V including kidney function. I talked my pcp into off labeling me when he wanted to put me on metformin for prediabetes prior to reduce it so I was a bit of a insulin resistance study for him... a Harvard grad he loves V
that's why I own 3x's more amrn … let's go baby quick jump to 10
I agree I think we are mostly reacting out of fear now.. if China is back to business as usual after essentially 3 months why aren't we going to rebound as well in the same or less time frame? I wish I had some dry powder this is a lifetime opportunity to make 50% in 6 months time
Time to back up truck..hunker down my arse
1 person dies from cvd every 38 seconds in U.S.
Israeli firm unveils kit to diagnose coronavirus, as 2nd team works on a vaccine | The Times of Israel
https://www.timesofisrael.com/israeli-firm-says-it-developed-kit-to-diagnose-coronavirus/
Could, GIA in USA isn't happening either.
most valuable for what? this shipped has long sailed with or without anyone on this boards blessing.. this is becoming some kind of ass kissing cult
a snarky riddle for acasti pumpers … how many amrn longs does it take to purchase acasti at 51 million??
A krillion .. I know that was really bad but I couldn't resist
I get what he said is it possible he was posturing? let's be clear 800 reps covering 300k pcp's, cardio's and endo's ain't going to cut it. The quality of the rep and her/his relationship with healthcare provider is beyond huge. I agree with my friend this is being sold
Folks, I read so much about GIA or buyout but hardly read anything about partnering with BP to utilize sales team and established relationships. Unlikely amarin can create an effective sales organization from scratch. The best sales people in this space aren't leaving big pharma positions with such a buy out hangover with amarin.
New commercial after NFC championship game beautifully done!!!!
my understanding on PPS to date is the ramp will be greatly reduced if GIA. Without a partner, Vascepa will be vastly under utilized in the U.S. market. We have the best mousetrap that many prescribers are unaware of to date. Consider there are 220k PCP's, 23k cardio's and 6500 endo's and 800 reps calling on 75k chosen prescribers. To change a physician's prescribing habits it is estimated to take up to 7 in office visits. Regardless of the number you use; suffice it to say dropping off fda approved literature is not going to ramp sales. I think JT is very conservative and mindful that market penetration isnt going to happen until DTC and a co promotor comes on board with 1k's of reps
Exactly a trial of 1 but I'll take it :)
My a1c dropped .5 point so I benefited also lost weight so what came first? No longer take metformin either; somehow V helps type 2 and in my case pre type 2 ...no diet changes maybe worse diet
good one Zum.. amazing how the MO chatter has subsided. Without a doubt in my mind, there have been calculated attacks since reduce it data was published. DS and or big Pharma the PPS has been suppressed .. if amrn does close to half a billion with limited label what happens to share price when every T2DM and anyone with trig's over 150 and a bit overweight globally are prescribed this drug? the market is supposedly forward thinking in amrn's case not so much. Is it the IP situation? but I don't think so.. amrn behaves like no other bio I've ever owned.. most get a head of themselves yet this one hasn't based on NNT or RRR that are extremely rare.. this would make for a good docu drama :)
flubber, typically you can just follow the money. like you inferred who has the most to lose? certainly DS is high on the list.. I think anybody who may have lost a fortune on reduce it still would have time to recoup those losses so my uneducated guess is DS
Warren Buffet is rumored to have said " The stock market is a device for transferring money from the impatient to the patient"
i'm buying with both fists! Christmas came early
also said if total plaque was the end point it would have been halted at interim for efficacy!!!!
Yes, he said full read out early 2020
No kidding Louie I'm exhausted wat too much drama. This will be my last over weighted position in a biotech too much can go wrong. My only concern going into this adcomm was the amount of money at stake would lead to corruption. I laughed at the afib and bleeding concerns. Add to it the MO b.s. and I'm done too much stress
No kidding Louie I'm exhausted wat too much drama. This will be my last over weighted position in a biotech too much can go wrong. My only concern going into this adcomm was the amount of money at stake would lead to corruption. I laughed at the afib and bleeding concerns. Add to it the MO b.s. and I'm done too much stress
the prospects of vascepa reaching millions or 10's of millions depends on 1. the label
2. the tier coverage hopefully updated formularies in early 2020
3. the effectiveness of the DTC tv and digital campaign
4. a large pharma partner
Amarin could hire 5k reps it would take them years to get this into the millions of scripts if that was their only strategy. DTC will drive this drug into the stratosphere provided tier coverage is very accommodating.
thanks bfost! yeah its like Jelis then a mega robust reduce it wasn't enough.. somehow highly purified EPA at 4g a day alone can't be the magic bullet.. so strange because it is the best adjunctive therapy with no adverse effects though the med. community isn't clamoring for it YET…
MO was mentioned at 2013 ADCOM and I posted 6 years ago why do we think that it will go away after reduce it is completed? crazy we are going around the same mountain...
xb, I think you hit the nail on the head .. not enough institutional investors as a percentage .. I shutter to think what is waiting for us to get it to say 85%.
DCF looking forward imo suggests way undervalued or someone knows something. with a label of 150+ with SOC T2DM on statins this is easily 2 billion in sales U.S. alone suggesting a market cap of at least 15 billion. only things holding this back would be FDA and or payors this is crazy cheap today
Anybody getting a margin rate below 5% I need some leverage with TD. I have a hefty margin account balance so I would be in the lowest rate category
i'm out of powder can't take advantage of today's price action.. I will hurry up and wait :) long since 09' I assure you this will be my last overweight bio position i'm too old for this shit! wasn't that sgt hulka from stripes while riding on the top of the ultra high tech RV :)
the tutes want their fill of shares; tomorrow gives them their best chance of picking up a boat load. i'll be buying as well love the game .. hard for a regular retail person to win. only thing that can keep vascepa from saving lives is greed.. all of us who have been long a long time prior to 2013 understand this stock behaves like no other .. today was a shock for everyone connected to amrn.. we will know in November if its more rigged than imaginable